The recipients of
Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical) which
supports "emerging research" that will drive the development of dermatology, have been decided.
April 1, 2026
ROHTO Pharmaceutical Co., Ltd. (Headquarters: Osaka City, Representative: Hidetoshi Segi) has been operating the "Rohto Dermatological Research Fund" since 2008 with the aim of contributing to the improvement and development of dermatology. Aiming for further development, it has been jointly operated with the Japanese Japanese Dermatological Association Association (hereinafter referred to as Japanese Dermatological Association) as the "Japanese Dermatological Association Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" since the selection of recipients in fiscal year 2018.
We are pleased to announce that two recipients have been selected for the 2026 fiscal year of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)."
About Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)
The Dermatological Research Fund (Endowment by Rohto Pharmaceutical) provides research funding for innovative and pioneering basic research that is expected to make a significant contribution to the future development of dermatology. Two recipients will each receive a research grant of 3 million yen to conduct two years of research.
Recipients of Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical) in 2020
| Name |
Affiliation |
Research topic |
| Takahashi Takehiro |
Tohoku University |
Comprehensive analysis of systemic-local immune and metabolic pathogenesis in alopecia areata |
| Hanako Yoshioka |
Osaka University |
Investigation of the mechanism responsible for switching between inflammation and anti-inflammatory states in subcutaneous fat. |
(In alphabetical order by branch of Japanese Dermatological Association)